Paul A Mahon is EVP & GENERAL COUNSEL of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 36,710 shares of UTHR, which is worth approximately $13.7 Million. The most recent transaction as insider was on Sep 16, 2021, when has been sold 6,000 shares (Common Stock) at a price of $111.0 per share, resulting in proceeds of $666,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.7K
0% 3M change
0.3% 12M change
Total Value Held $13.7 Million

PAUL A MAHON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Sep 02 2021
SELL
Open market or private sale
$1,269,840 $211.64 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Sep 02 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Aug 23 2021
SELL
Open market or private sale
$1,237,080 $206.18 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Aug 23 2021
BUY
Exercise of conversion of derivative security
$666,000 $111.0 p/Share
6,000 Added 12.4%
42,369 Common Stock
Aug 05 2021
SELL
Sale (or disposition) back to the issuer
$1,129,810 $205.42 p/Share
5,500 Reduced 13.14%
36,369 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$522,280 $94.96 p/Share
5,500 Added 11.61%
41,869 Common Stock
Jul 15 2021
SELL
Sale (or disposition) back to the issuer
$1,105,140 $184.19 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Jul 15 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.4%
42,369 Common Stock
Jul 01 2021
SELL
Sale (or disposition) back to the issuer
$1,108,020 $184.67 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Jul 01 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.4%
42,369 Common Stock
Jun 17 2021
SELL
Sale (or disposition) back to the issuer
$1,094,460 $182.41 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Jun 17 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.4%
42,369 Common Stock
Jun 03 2021
SELL
Sale (or disposition) back to the issuer
$1,051,440 $175.24 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Jun 03 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.4%
42,369 Common Stock
May 20 2021
SELL
Sale (or disposition) back to the issuer
$1,146,540 $191.09 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
May 20 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.4%
42,369 Common Stock
May 06 2021
SELL
Sale (or disposition) back to the issuer
$1,152,420 $192.07 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
May 06 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.4%
42,369 Common Stock
Apr 15 2021
SELL
Sale (or disposition) back to the issuer
$1,210,020 $201.67 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Apr 15 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.4%
42,369 Common Stock
Apr 01 2021
SELL
Sale (or disposition) back to the issuer
$1,154,040 $192.34 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Apr 01 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.4%
42,369 Common Stock
Mar 18 2021
SELL
Sale (or disposition) back to the issuer
$1,022,100 $170.35 p/Share
6,000 Reduced 14.16%
36,369 Common Stock
Mar 18 2021
BUY
Exercise of conversion of derivative security
$569,760 $94.96 p/Share
6,000 Added 12.4%
42,369 Common Stock
PAM

Paul A Mahon

EVP & GENERAL COUNSEL
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR